Globally 14M people undergo colorectal surgery. Anastomosis is a common procedure in colorectal surgery, where two parts of the colon-rectum are joined after the surgery. Almost 20% of colorectal surgeries are vulnerable to anastomotic leakage, the symptoms of which are not felt on time. This might lead to septic shock, increasing the mortality by 32% and hospital readmission charges by 25K USD, thus imposing a global healthcare burden of 29M USD annually. There is a clinical need to monitor anastomotic integrity.
Our flagship product provides on-demand monitoring of the surgical site for anastomotic integrity and alerts on time in-case of anastomotic leakage, thereby enabling early medical intervention to avoid fatality. We have an international patent pending for the technology.
We have done >100 interviews across different stakeholders to validate the market and clinical needs. Surgeons and hospitals are our customers and we have a market potential of upto 6B USD.
This is a scalable, platform technology that can be used to monitor deep, invisible sites on a real-time basis. This technology can be extended to other medical and non-medical applications.
TECHNOLOGY FEATURES & SPECIFICATIONS
This is an unique radiofrequency identification (RFID) sensing and wireless powering platform to enable on-demand monitoring of surgical sites.
This technology comprises of an implantable passive sensor tag attached at the site of the surgery and a hand-held reader that powers and communicates with the tag. This reader provides alert on-time.
Our beach head market is colorectal surgeries. This product will potentially monitor for anastomotic leak.
But the growth strategy includes looking at other post-operative complications. Our primary interviews have also shown that this technology can be used in conjunction with other non-medical applications like detection of food spoilage and crop health.